Details for Patent: 8,785,420

Which drugs does patent 8,785,420 protect, and when does it expire?

Patent 8,785,420 protects EPIDUO FORTE and is included in one NDA.

This patent has thirty-five patent family members in twenty-two countries.

Summary for Patent: 8,785,420

Title:	Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Abstract:	Acne lesions, whether of inflammatory and/or non-inflammatory type, are simultaneously or sequentially treated and their number reduced, via daily topical regimen, with the combination or association of adapalene or pharmaceutically acceptable salt thereof and benzoyl peroxide (BPO).
Inventor(s):	Abou Chacra Vernet; Marie-Line (Nice, FR), Gross; Denis (Callian, FR), Loesche; Christian (Valbonne, FR), Poncet; Michel (Mougins, FR)
Assignee:	Galderma Research & Development (Biot, FR)
Application Number:	13/351,986
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,785,420
Patent Claim Types: see list of patent claims	Use; Compound;

Drugs Protected by US Patent 8,785,420

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Galderma Labs	EPIDUO FORTE	adapalene; benzoyl peroxide	GEL;TOPICAL	207917-001	Jul 15, 2015	AB	RX	Yes	Yes						TREATMENT OF ACNE

Foreign Priority and PCT Information for Patent: 8,785,420

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	06 52968	Jul 13, 2006

International Family Members for US Patent 8,785,420

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	061989
Australia	2007274288
Brazil	PI0713182
Canada	2656456
China	101541320
Colombia	6150136